5 strategies for biotech startups to outlast a market downturn
TechCrunch
MARCH 16, 2023
James Coates is the Health and Human Performance principal at Decisive Point , a venture capital and advisory firm that invests in and supports startups with emerging defense technologies. This is especially true for biotech startups, where investment needs are higher and success timelines can be much longer.
Let's personalize your content